Journal article · 2020 · Open access

The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing

Jessica Mancilla-de-la-Cruz, Marisela Rodríguez-Salvador, Laura Ruiz‐Cantu

Foresight-Russia, 14(3), 55–70 · Published 25 September 2020 · DOI 10.17323/2500-2597.2020.3.55.70

Open PDFView at the publisherCite this paper

In brief

“The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing” is a 2020 journal article by Jessica Mancilla-de-la-Cruz and 2 co-authors, published in Foresight-Russia. OpenAlex counts 12 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Foresight-Russia.

Citations
12
Most cited in
2025 (4)
Field-weighted impact
0.58
References
30
Authors
3

Abstract

Additive manufacturing (AM) is increasingly gaining a presence in the pharmaceutical industry, specifically in the reconfiguration of drug delivery systems wherein new products are being developed for administering pharmaceuticals inside the body, and drug testing systems wherein complex tissues are created to analyze medical treatments. This paper proposes a novel methodology of Competitive Technology Intelligence (CTI) to uncover the evolution of new drug delivery products where additive manufacturing is present. Using the multiple linear regression analysis and hype cycle model as a conceptual basis, we processed data from scientific papers and patents indexed by Scopus and PatSnap for the period of 2004–2019. The outcomes of this study can create a relevant knowledge base for decision-making on introducing novel technologies such as AM. Industrial and academic communities are devoting important efforts toward the advancement of AM in the health industry, especially pharmaceuticals. It is expected that this technology will bring new solutions to address fundamental global health problems. However, this technology is still in its very early stage. Therefore, investments should focus on research and development (R&D) to build a solid foundation for commercialization in the next decade.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mancilla-de-la-Cruz, J., Rodríguez-Salvador, M., & Ruiz‐Cantu, L. (2020). The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing. Foresight-Russia, 14(3), 55–70. https://doi.org/10.17323/2500-2597.2020.3.55.70

MLA 9

Mancilla-de-la-Cruz, Jessica, et al. “The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing.” Foresight-Russia, vol. 14, no. 3, 2020, pp. 55–70. https://doi.org/10.17323/2500-2597.2020.3.55.70.

Chicago

Mancilla-de-la-Cruz, Jessica, Marisela Rodríguez-Salvador, and Laura Ruiz‐Cantu. 2020. “The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing.” Foresight-Russia 14 (3): 55–70. https://doi.org/10.17323/2500-2597.2020.3.55.70.

Harvard

Mancilla-de-la-Cruz, J., Rodríguez-Salvador, M. and Ruiz‐Cantu, L. (2020) ‘The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing’, Foresight-Russia, 14(3), pp. 55–70. doi:10.17323/2500-2597.2020.3.55.70.

IEEE

J. Mancilla-de-la-Cruz, M. Rodríguez-Salvador, and L. Ruiz‐Cantu, “The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing,” Foresight-Russia, vol. 14, no. 3, pp. 55–70, 2020, doi: 10.17323/2500-2597.2020.3.55.70.

BibTeX

@article{mancilladelacruz2020next,
  title     = {{The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing}},
  author    = {Mancilla-de-la-Cruz, Jessica and Rodríguez-Salvador, Marisela and Ruiz‐Cantu, Laura},
  journal   = {Foresight-Russia},
  year      = {2020},
  volume    = {14},
  number    = {3},
  pages     = {55--70},
  doi       = {10.17323/2500-2597.2020.3.55.70},
  url       = {https://doi.org/10.17323/2500-2597.2020.3.55.70}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202233
202322
202422
202544
202611

Its field-weighted citation impact is 0.58: it has been cited 0.58 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Industrial and Manufacturing Engineering › Additive Manufacturing and 3D Printing Technologies

  • additive manufacturing
  • 3D printing
  • drug delivery systems
  • patents
  • R&D investment
  • technology commercialization

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Mancilla-de-la-Cruz, J., Rodríguez-Salvador, M., & Ruiz‐Cantu, L. (2020). The Next Pharmaceutical Path: Determining Technology Evolution in Drug Delivery Products Fabricated with Additive Manufacturing. Foresight-Russia, 14(3), 55–70. https://doi.org/10.17323/2500-2597.2020.3.55.70

How many times has this paper been cited?

12 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Foresight-Russia: sign in and open the PDF from this page.

Who wrote this paper?

Jessica Mancilla-de-la-Cruz, Marisela Rodríguez-Salvador, Laura Ruiz‐Cantu.

What is the DOI of this paper?

10.17323/2500-2597.2020.3.55.70, permanently at https://doi.org/10.17323/2500-2597.2020.3.55.70. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.